Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Acad Consult Liaison Psychiatry ; 62(5): 493-500, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34048960

RESUMEN

BACKGROUND: As the science of consultation-liaison psychiatry advances, the Academy of Consultation-Liaison Psychiatry's Guidelines and Evidence-Based Medicine Subcommittee reviews articles of interest to help academy members remain familiar with the latest in evidence-based practice. OBJECTIVE: We identify the 10 most important articles for clinical practice in consultation-liaison psychiatry from 2020 using the new Importance and Quality instrument for assessing scientific literature. METHODS: The subcommittee published annotated abstracts for 97 articles on the academy website in 2020. Reviewers then rated all articles on clinical importance to practice and quality of scholarship using the Importance and Quality instrument. We describe the 10 articles with the highest aggregate scores and analyze the reliability of Importance and Quality instrument. RESULTS: Twenty-four raters identified the top 10 scoring articles of 2020. These articles provide practical guidance on key areas of consultation-liaison psychiatry including management of COVID-19, lithium treatment for complex patients, medical risks among patients with severe mental illness, and substance use disorders in medical settings. The assessment instrument demonstrated good to excellent interrater reliability. CONCLUSION: These articles offer valuable guidance for consultation-liaison psychiatrists regardless of their practice area. Collaborative literature reviews with standardized assessments help clinicians deliver evidence-based care and foster a high standard of practice across the specialty.


Asunto(s)
Psiquiatría , Derivación y Consulta , COVID-19/psicología , Cannabis/efectos adversos , Delirio/clasificación , Encefalitis , Medicina Basada en la Evidencia , Humanos , Compuestos de Litio/efectos adversos , Compuestos de Litio/uso terapéutico , Trastornos Mentales/complicaciones , Trastornos Mentales/mortalidad , Atención Plena , Neoplasias/complicaciones , Neoplasias/mortalidad , Neoplasias/psicología , Reproducibilidad de los Resultados , Enfermedades de Transmisión Sexual/epidemiología
2.
J Psychosom Res ; 129: 109908, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31884302

RESUMEN

OBJECTIVE: Medical events such as myocardial infarction and cancer diagnosis can induce symptoms of posttraumatic stress disorder (PTSD). The optimal treatment of PTSD symptoms in this context is unknown. METHODS: A literature search of 6 biomedical electronic databases was conducted from database inception to November 2018. Studies were eligible if they used a randomized design and evaluated the effect of treatments on medical event-induced PTSD symptoms in adults. A random effects model was used to pool data when two or more comparable studies were available. RESULTS: Six trials met full inclusion criteria. Studies ranged in size from 21 to 81 patients, and included patients with PTSD induced by cardiac events, cancer, HIV, multiple sclerosis, and stem cell transplantation. All trials assessed psychological interventions. Two trials comparing a form of exposure-based cognitive behavioral therapy (CBT) with assessment-only control found that CBT resulted in lower PTSD symptoms [Hedges's g = -0.47, (95% CI -0.82 - -0.12), p = .009]. A third trial compared imaginal exposure (another form of exposure-based CBT) with an attention control and found a trend toward reduced PTSD symptoms. Three trials compared eye movement desensitization and reprocessing (EMDR) with active psychological treatments (imaginal exposure, conventional CBT, and relaxation therapy), and found that EMDR was more effective. CONCLUSION: CBT and EMDR may be promising approaches to reducing PTSD symptoms due to medical events. However, additional trials are needed in this patient population.


Asunto(s)
Terapia Cognitivo-Conductual/métodos , Trastornos por Estrés Postraumático/psicología , Adulto , Humanos
3.
J Psychiatr Pract ; 24(1): 51-55, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29320384

RESUMEN

The increasing prevalence of cannabis use in the United States requires awareness of cannabis-related disorders and familiarity with treatment options. We present a case of cannabinoid hyperemesis syndrome that required psychiatric consultation for diagnostic clarification and effective treatment with intravenous haloperidol. Literature from emergency medicine, toxicology, and gastroenterology is reviewed, including proposed diagnostic criteria for cannabinoid hyperemesis syndrome and reported off-label treatment options, with a specific focus on clinical questions facing the practicing psychiatrist regarding this emerging disorder.


Asunto(s)
Cannabinoides/efectos adversos , Abuso de Marihuana/complicaciones , Vómitos/inducido químicamente , Adulto , Antieméticos/uso terapéutico , Humanos , Masculino , Síndrome , Vómitos/diagnóstico , Vómitos/tratamiento farmacológico , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA